← Leaderboards
Brent E Korba
Georgetown University
$1,542,642
Attributed
$1,542,642
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $439.2K · FY2009–11$500K$375K$250K$125K$0
'09
'10
'11
Funding mix
By agency
NIH$1,542,642 · 3
By mechanism
N01$1,542,642 · 3
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Paul D. Roepe$12,582,623
- John L. Marshall$2,076,333
- Mary A Young$42,030,350
- Christopher A Loffredo$8,219,689
- Habtom W Ressom$10,889,463
Others in their field
Top investigators on “Antiviral Agents”
- Constance Ann Benson · University Of California, San Diego$209,152,068
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$120,325,769
- Judith S. Currier · University Of California Los Angeles$102,391,456
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Sharon A Nachman · Johns Hopkins University$77,262,665
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,660,403
Research focus
Antiviral AgentsIn VitroContractsVirus DevelopmentCell LineHepatitis B VirusIn Vitro TestingMaintenanceScreening ProcedureViralAntimicrobialTissue /Cell CultureProgramsDrug Screening /EvaluationHepatitis BResearch InfrastructureHepatitis C VirusDrug Development
Grant awards (5)
Task B06: In Vitro Screening for Hepatitis B$282,000
N01 · FY2011 · AI · contact PI
In Vitro Assessments for Antimicrobial Activity$25,000
N01 · FY2011 · AI · contact PI
In Vitro Antiviral Screening Program$439,191
N01 · FY2010 · AI · contact PI
In Vitro Antiviral Screening Program$439,191
N01 · FY2009 · AI · contact PI
IN VITRO ANTIVIRAL SCREENS$357,260
N01 · FY2000 · AI